Article Details

Hansa Biopharma AB (publ) (OTCMKTS:HNSBF) Price Target Raised to SEK 244

Retrieved on: 2022-07-23 14:23:53

Tags for this article:

Click the tags to see associated articles and topics

Hansa Biopharma AB (publ) (OTCMKTS:HNSBF) Price Target Raised to SEK 244. View article details on hiswai:

Excerpt

Hansa Biopharma AB (publ), a biopharmaceutical company, develops immunomodulatory treatments for enabling transplants and rare immunoglobulin G ...

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up